6-7-dihydroxyflavone and Epilepsy

6-7-dihydroxyflavone has been researched along with Epilepsy* in 2 studies

Other Studies

2 other study(ies) available for 6-7-dihydroxyflavone and Epilepsy

ArticleYear
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2022, Volume: 19, Issue:6

    Temporal lobe epilepsy often manifests months or even years after an initial epileptogenic insult (e.g., stroke, trauma, status epilepticus) and, therefore, may be preventable. However, no such preventive treatment is currently available. Aim of this study was to test an antioxidant agent, 7,8-dihydroxyflavone (7,8-DHF), that is well tolerated and effective in preclinical models of many neurological disorders, as an anti-epileptogenic drug. However, 7,8-DHF also acts as a TrkB receptor agonist and, based on the literature, this effect may imply an anti- or a pro-epileptogenic effect. We found that low- (5 mg/kg), but not high-dose 7,8-DHF (10 mg/kg) can exert strong anti-epileptogenic effects in the lithium-pilocarpine model (i.e., highly significant reduction in the frequency of spontaneous seizures and in the time to first seizure after status epilepticus). The mechanism of these different dose-related effects remains to be elucidated. Nonetheless, considering its excellent safety profile and antioxidant properties, as well as its putative effects on TrkB receptors, 7,8-DHF represents an interesting template for the development of effective and well-tolerated anti-epileptogenic drugs.

    Topics: Animals; Antioxidants; Disease Models, Animal; Epilepsy; Flavones; Receptor, trkB; Seizures; Status Epilepticus

2022
Predicting and treating stress-induced vulnerability to epilepsy and depression.
    Annals of neurology, 2015, Volume: 78, Issue:1

    Accumulation of stressful events can render individuals susceptible to develop epilepsy and comorbidities. Whether such vulnerability can be predicted and reversed is not known. Here we show that social defeat, although not producing depression by itself, produced in 50% of rats reduced threshold for status epilepticus (SE), accelerated epileptogenesis, and once epilepsy was induced, depression-like profile and cognitive deficits. Low serum brain-derived neurotrophic factor (BDNF) levels measured before SE identified this vulnerable population. Treatment with a BDNF analog before SE prevented the occurrence of comorbidities. Thus, vulnerability to comorbidities after epilepsy onset due to unresolved past stressful events may be predicted and reversed.

    Topics: Allostasis; Animals; Brain-Derived Neurotrophic Factor; Cognition Disorders; Depression; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; Flavones; Hypothalamo-Hypophyseal System; Kainic Acid; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Social Environment; Status Epilepticus; Stress, Psychological

2015